Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

TELESTA THERAPEUTICS INC T.TST

"Telesta Therapeutics Inc is a biopharmaceutical company. The Company is engaged in the research, development, manufacturing and commercialization of human health products and technologies."


TSX:TST - Post by User

Post by SWNEon Jun 27, 2013 8:25pm
182 Views
Post# 21578039

Wow!

Wow!I must admit to being swayed by these Biovail Boys. Graeme et al are betting everything on their last three rings tossed at the fair to win the 'big teddy bear'. 

I now believe how I will vote. If Graeme et al sell AH and we all get $3.00/share as a dividend, plus an equal number of shares in Urocidin, I will vote for them. If not, I'm nearly sure I will vote for the Biovail Boys. This is because they will offer a better long term strategy for enhanced shareholder value, due to AH profits and minimal burn. How many Klondike prospectors didnt hit pay dirt, as compared to those who did? This is our risk with Urocidin. Endo wouldn't dump it if it had a chance.

Graeme et al have shown reckless behavior wrt Urocidin and Econiche and the VMC and GMP.

Like my Grand Master Lorneg has stated many times, a company should concentrate on its core strengths, and never clone the executive. This company has failed on both counts. Now it is failing its shareholder/owners. And now it is horribly ripe for the plucking. RIP's.
<< Previous
Bullboard Posts
Next >>